PROGRAM MANAGER: Pam Semanik
OPPORTUNITY: Licensing, product acquisition, contract research, proof of concept leading to scale-up to manufacturing, joint development, supplier agreement.
Phase 1 – Feasibility evaluation, proof of concept
Phase 2 – Technology adaptation/optimization
All terms to be negotiated between the Solution Provider(s) and the Client sponsor, as warranted.
SOLUTION PROVIDER HELP DESK:
NineSigma, representing a Global Leader in medical devices and specializing in hydrogel materials, invites proposals for technologies that can impart antioxidant properties to hydrogel polymers.
Oxidative stress induces lipid peroxidation on the surfaces of medical devices that adsorb lipids to their surfaces. These lipid peroxidases (LPOs) are suspected of detrimental effects in the surrounding tissues. Some examples of LPOs include lipid hydroperoxides and their secondary products (aldehydes and oxidative stress markers such as malondialdehyde, propanol, hexanal, and 4-hydroxynonenal.
The RFP sponsor is seeking innovations that prevent, minimize, or mediate oxidation at the surface of a hydrogel polymer for up to 16 hours or more. Ideally, the proposed technology will provide antioxidant properties for up to one month.
The technology must:
Possible approaches might include, but are not limited to:
The following approaches are not of interest:
To respond, please make sure you are registered in NineSights, as it will prompt you to log in. Then, use the Response options at the top or bottom of the page. You may submit supplemental files in addition to your completed response form.
Appropriate responses will use the response form and address the following:
Other Request information includes:
APPROPRIATE RESPONSES TO THIS REQUEST
Responses from companies (small to large), academic researchers, other research institutes, consultants, venture capitalists, entrepreneurs, or inventors are welcome. For example:
You represent a company or university that has demonstrated a proof of concept.
You represent a company or university that has reduced method to practice at lab scale.
You represent a company or university that has developed a method for use at pilot scale.
You represent a company or university that has demonstrated a method ready for implementation at industrial scale.
You represent a technology transfer agency that represents an inventor or technology holder who can demonstrate an approach to address the request.
You represent a university research department that has a bench-scale demonstration ready to adapt.
You represent a university research department that has an undeveloped pathway with a high probability of success.